ACC 2022 Conference Coverage
ACC 2022: Long-term Safety and Tolerability of Acoramidis in Symptomatic Transthyretin Amyloid Cardiomyopathy
By
ACC 2022 Conference Coverage
FEATURING
Ahmad Masri
By
ACC 2022 Conference Coverage
FEATURING
Ahmad Masri
Login to view comments.
Click here to Login